<DOC>
<DOCNO>
EP-0009425
</DOCNO>
<TEXT>
<DATE>
19800402
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/44 C07D-471/00 C07D-213/75 C07D-213/77 <main>C07D-471/04</main> C07D-471/04 C07D-213/74 C07D-213/00 
</IPC-CLASSIFICATIONS>
<TITLE>
novel naphtyridine derivatives and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
bellon labor sa roger fr<sep>dainippon pharmaceutical co jp  <sep>dainippon pharmaceutical co., ltd.<sep>societe anonyme dite:  laboratoire roger bellon<sep>dainippon pharmaceutical co., ltd.25, doshomachi 3-chome higashi-kuosaka-shi, osaka 541jp<sep>société anonyme dite: laboratoire roger bellon159, avenue a. perettif-92201 neuilly-sur-seinefr<sep>dainippon pharmaceutical co., ltd.<sep>societe anonyme dite:  laboratoire roger bellon<sep>
</APPLICANT>
<INVENTOR>
matsumoto jun-ichi<sep>nishimura yoshiro<sep>takase yoshiyuki<sep>matsumoto, jun-ichi<sep>nishimura, yoshiro<sep>takase, yoshiyuki<sep>matsumoto, jun-ichi3-39, matsugaoka 3-chome takatsuki-shiosaka-fujp<sep>nishimura, yoshirodainippon seiyaku neyagawa-ryo, 3-17 naritahigashigaoka, neyagawa-shi osaka-fujp<sep>takase, yoshiyuki401, aza ishizuka, misono amagasaki-shihyogo-kenjp<sep>matsumoto, jun-ichi<sep>nishimura, yoshiro<sep>takase, yoshiyuki<sep>matsumoto, jun-ichi3-39, matsugaoka 3-chome takatsuki-shiosaka-fujp<sep>nishimura, yoshirodainippon seiyaku neyagawa-ryo, 3-17 naritahigashigaoka, neyagawa-shi osaka-fujp<sep>takase, yoshiyuki401, aza ishizuka, misono amagasaki-shihyogo-kenjp<sep>
</INVENTOR>
<ABSTRACT>
1,8-naphthyridine compounds of the following  formula    wherein x is a halogen atom especially fluorine or  chlorine, r₁ is an ethyl or vinyl group and r₂ is  hydrogen  atom or a lower alkyl group containing 1 to 6 carbon  atoms, as well as hydrates and nontoxic pharmaceutically  acceptable salts thereof.  said compounds have high antibacterial activities  against gram-positive and gram-negative bacteria in­ cluding pseudomonas aeruginosa and low toxicity and  can be used as antibacterial agents.  
</ABSTRACT>
</TEXT>
</DOC>
